At a glance
- Originator Pfizer
- Class Antidepressants; Anxiolytics; Obesity therapies
- Mechanism of Action Serotonin 1B receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Obesity
Most Recent Events
- 15 Mar 2000 No-Development-Reported for Obesity (Unknown route)
- 10 Sep 1998 Preclinical development for Obesity (Unknown route)